Tag: IMFINZI
IMFINZI® (durvalumab) plus chemotherapy significantly improved pathologic comple… – Press Release
First global Phase III trial of immunotherapy and chemotherapy combination to demonstrate clinical benefit in this setting
Trial will continue to assess event-free survival
Positive...